A. Yaïci

1.7k total citations · 1 hit paper
18 papers, 1.2k citations indexed

About

A. Yaïci is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Yaïci has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Genetics and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Yaïci's work include Pulmonary Hypertension Research and Treatments (16 papers), Vascular Anomalies and Treatments (9 papers) and Systemic Sclerosis and Related Diseases (3 papers). A. Yaïci is often cited by papers focused on Pulmonary Hypertension Research and Treatments (16 papers), Vascular Anomalies and Treatments (9 papers) and Systemic Sclerosis and Related Diseases (3 papers). A. Yaïci collaborates with scholars based in France, Morocco and Portugal. A. Yaïci's co-authors include Marc Humbert, Olivier Sitbon, Xavier Jaïs, David Montani, Gérald Simonneau, Florence Parent, Laurent Savale, Dermot S. O’Callaghan, Rogério Souza and G. Simonneau and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Lara D. Veeken.

In The Last Decade

A. Yaïci

14 papers receiving 1.2k citations

Hit Papers

Survival in incident and prevalent cohorts of patients wi... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Yaïci France 9 1.1k 554 362 120 119 18 1.2k
Shelley Shapiro United States 13 1.4k 1.2× 781 1.4× 234 0.6× 174 1.4× 99 0.8× 29 1.5k
Nicola Benjamin Germany 19 1.1k 1.0× 728 1.3× 143 0.4× 147 1.2× 79 0.7× 74 1.3k
Abby Krichman United States 7 1.3k 1.2× 867 1.6× 308 0.9× 61 0.5× 119 1.0× 15 1.4k
Kathy Feldkircher United States 5 1.2k 1.1× 774 1.4× 288 0.8× 61 0.5× 117 1.0× 8 1.3k
Clare Das United Kingdom 4 897 0.8× 430 0.8× 188 0.5× 380 3.2× 67 0.6× 4 996
Masahisa Masuda Japan 15 594 0.5× 327 0.6× 120 0.3× 15 0.1× 45 0.4× 40 697
Kamal K. Mubarak United States 12 455 0.4× 221 0.4× 240 0.7× 11 0.1× 98 0.8× 22 813
Bernard Coleiro Malta 6 514 0.5× 119 0.2× 84 0.2× 514 4.3× 54 0.5× 14 737
Rosa Laura E. van Loon Netherlands 13 967 0.9× 727 1.3× 174 0.5× 10 0.1× 577 4.8× 19 1.2k
Christoph B. Wiedenroth Germany 21 1.0k 0.9× 804 1.5× 248 0.7× 6 0.1× 66 0.6× 70 1.2k

Countries citing papers authored by A. Yaïci

Since Specialization
Citations

This map shows the geographic impact of A. Yaïci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Yaïci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Yaïci more than expected).

Fields of papers citing papers by A. Yaïci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Yaïci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Yaïci. The network helps show where A. Yaïci may publish in the future.

Co-authorship network of co-authors of A. Yaïci

This figure shows the co-authorship network connecting the top 25 collaborators of A. Yaïci. A scholar is included among the top collaborators of A. Yaïci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Yaïci. A. Yaïci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Thoreau, Benjamin, Philippe Chafey, Guilhem Clary, et al.. (2025). Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD). Lara D. Veeken. 64(6). 4041–4050.
2.
Natali, Delphine, Xavier Jaïs, Laurent Savale, et al.. (2011). Chronic Thromboembolic Pulmonary Hypertension Associated With Indwelling Port-A-Cath® Central Venous Access Systems. A2409–A2409. 4 indexed citations
3.
Hachulla, É., David Launay, A. Yaïci, et al.. (2010). Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. Lara D. Veeken. 49(5). 940–944. 46 indexed citations
4.
Girerd, Barbara, David Montani, Florence Coulet, et al.. (2010). Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 ( ALK1 ) Mutation. American Journal of Respiratory and Critical Care Medicine. 181(8). 851–861. 215 indexed citations
5.
Humbert, Marc, Olivier Sitbon, A. Yaïci, et al.. (2010). Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. European Respiratory Journal. 36(3). 549–555. 470 indexed citations breakdown →
7.
Degano, Bruno, Marcel Guillaume, Xavier Jaïs, et al.. (2009). HIV-Associated Pulmonary Arterial Hypertension: Survival and Prognostic Factors in the Current Therapeutic Era.. A2655–A2655.
8.
Montani, David, Barbara Girerd, Florence Coulet, et al.. (2009). Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of ACVRL1 (ALK1) Mutation.. A2659–A2659.
9.
Savale, Laurent, Olivier Sitbon, Jérôme Le Pavec, et al.. (2009). Addition of Sildenafil to First Line Bosentan Therapy in Patients with Idiopathic Pulmonary Arterial Hypertension.. A3368–A3368. 1 indexed citations
11.
Montani, David, Laura Price, Peter Dorfmüller, et al.. (2008). Pulmonary veno-occlusive disease. European Respiratory Journal. 33(1). 189–200. 186 indexed citations
12.
Degano, Bruno, A. Yaïci, Jérôme Le Pavec, et al.. (2008). Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension. European Respiratory Journal. 33(1). 92–98. 76 indexed citations
13.
Souza, Rogério, Marc Humbert, Benjamin Sztrymf, et al.. (2007). Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. European Respiratory Journal. 31(2). 343–348. 84 indexed citations
14.
Sztrymf, Benjamin, A. Yaïci, Peter Dorfmüller, et al.. (2007). Hypertension artérielle pulmonaire postembolique tumorale. Revue des Maladies Respiratoires. 24(3). 359–366. 11 indexed citations
15.
Sztrymf, Benjamin, A. Yaïci, Laurent Bertoletti, et al.. (2007). 513 Caractéristiques cliniques et biologiques, survie et facteurs pronostiques des exacerbations aiguës d’hypertension artérielle pulmonaire. Revue des Maladies Respiratoires. 24. 154–154. 1 indexed citations
16.
Sztrymf, Benjamin, A. Yaïci, Xavier Jaïs, et al.. (2005). Génétique de l’hypertension artérielle pulmonaire: données récentes et applications pratiques. Revue des Maladies Respiratoires. 22(5). 796–805. 5 indexed citations
17.
Humbert, Marc, A. Yaïci, Benjamin Sztrymf, & David Montani. (2004). Hypertension artérielle pulmonaire : de la génétique aux traitements. Revue de Pneumologie Clinique. 60(4). 196–201. 3 indexed citations
18.
Cracowski, Jean‐Luc, A. Yaïci, Olivier Sitbon, et al.. (2004). Évaluation pronostique de biomarqueurs dans l’hypertension artérielle pulmonaire. Revue des Maladies Respiratoires. 21(6). 1137–1143. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026